Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer

Endocrine therapy is the mainstay of adjuvant treatment for patients with luminal breast cancer. Despite ongoing advances in endocrine therapy to date, a proportion of patients ultimately develop endocrine resistance, resulting in failure of therapy and poor prognosis. Therefore, as part of the grow...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Main Authors: Alfarsi, Lutfi H., El Ansari, Rokaya, Masisi, Brendah K., Parks, Ruth, Mohammed, Omar J, Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7352383/
https://ncbi.nlm.nih.gov/pubmed/32545448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12061549
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares